Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IVA Inventiva S.A.

未开盘 11-25 16:00:00 EST

2.67

+0.06

+2.10%

盘后2.67

+0.000.00%

16:17 EST

最高2.76	最低2.55	成交量2.28万
今开2.55	昨收2.62	日振幅8.15%
总市值2.32亿	流通市值4,853万	总股本8,708万
成交额6.02万	换手率0.13%	流通股本1,817万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IVA","market":"US","secType":"STK","nameCN":"Inventiva S.A.","latestPrice":2.67,"timestamp":1732568400000,"preClose":2.615,"halted":0,"volume":22796,"hourTrading":{"tag":"盘后","latestPrice":2.67,"preClose":2.67,"latestTime":"16:17 EST","volume":41,"amount":111.9,"timestamp":1732569468070},"delay":0,"floatShares":18174220,"shares":87077695,"eps":-2.218419,"marketStatus":"未开盘","marketStatusCode":0,"change":0.055,"latestTime":"11-25 16:00:00 EST","open":2.55,"high":2.76,"low":2.5469,"amount":60172.048048,"amplitude":0.081491,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.218419,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732611600000},"adr":0,"listingDate":1594353600000,"adjPreClose":2.615,"adrRate":1,"postHourTrading":{"tag":"盘后","latestPrice":2.67,"preClose":2.67,"latestTime":"16:17 EST","volume":41,"amount":111.9,"timestamp":1732569468070},"volumeRatio":1.49048},"requestUrl":"/m/hq/s/IVA","defaultTab":"news","newsList":[{"id":"2486030108","title":"Inventiva Sa盘中异动 快速上涨5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486030108","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486030108?lang=zh_cn&edition=full","pubTime":"2024-11-26 01:18","pubTimestamp":1732555106,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日01时18分，Inventiva Sa股票出现波动，股价急速拉升5.54%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为1.70%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112601182698e4477d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112601182698e4477d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2485298735","title":"Inventiva Sa盘中异动 快速下挫5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298735?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:57","pubTimestamp":1732291061,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时57分，Inventiva Sa股票出现波动，股价大幅下跌5.64%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.47%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122235742abd7b68a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122235742abd7b68a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2485418623","title":"Inventiva Sa盘中异动 股价大跌5.84%报2.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485418623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485418623?lang=zh_cn&edition=full","pubTime":"2024-11-21 23:05","pubTimestamp":1732201501,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日23时05分，Inventiva Sa股票出现波动，股价急速跳水5.84%。截至发稿，该股报2.58美元/股，成交量1449股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.73%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112123050195be4f13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112123050195be4f13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2482480886","title":"Inventiva Sa盘中异动 快速拉升6.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482480886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482480886?lang=zh_cn&edition=full","pubTime":"2024-11-09 01:11","pubTimestamp":1731085879,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日01时11分，Inventiva Sa股票出现异动，股价大幅上涨6.74%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.89%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109011119abae99d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109011119abae99d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2480581639","title":"Inventiva Sa盘中异动 早盘大幅跳水5.45%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480581639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480581639?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:33","pubTimestamp":1730730790,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时33分，Inventiva Sa股票出现波动，股价快速下挫5.45%。截至发稿，该股报2.60美元/股，成交量106股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.22%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422331095bdca1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422331095bdca1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2478933965","title":"Inventiva Sa盘中异动 快速上涨7.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478933965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478933965?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:37","pubTimestamp":1729863468,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时37分，Inventiva Sa股票出现波动，股价快速上涨7.66%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.66%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521374998e3e7f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521374998e3e7f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","ELAB","BK4183","BK4139"],"gpt_icon":0},{"id":"2478651983","title":"Inventiva Sa盘中异动 临近午盘股价大跌7.01%报2.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478651983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478651983?lang=zh_cn&edition=full","pubTime":"2024-10-24 23:44","pubTimestamp":1729784675,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日23时44分，Inventiva Sa股票出现异动，股价大幅跳水7.01%。截至发稿，该股报2.52美元/股，成交量1.5753万股，换手率0.03%，振幅5.54%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.13%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102423443598e3e49e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102423443598e3e49e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2477538212","title":"Inventiva Sa盘中异动 股价大跌5.13%报2.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477538212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477538212?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:32","pubTimestamp":1729690362,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时32分，Inventiva Sa股票出现异动，股价大幅下挫5.13%。截至发稿，该股报2.59美元/股，成交量7424股，换手率0.01%，振幅1.83%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.17%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023213242a1e3ffb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023213242a1e3ffb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2477866918","title":"Inventiva Sa盘中异动 大幅拉升5.70%报2.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477866918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477866918?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:31","pubTimestamp":1729517469,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时31分，Inventiva Sa股票出现波动，股价快速拉升5.70%。截至发稿，该股报2.78美元/股，成交量6.0029万股，换手率0.11%，振幅0.76%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.18%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121310998e3d81b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121310998e3d81b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2476845230","title":"Inventiva Sa盘中异动 大幅拉升5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476845230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476845230?lang=zh_cn&edition=full","pubTime":"2024-10-18 21:32","pubTimestamp":1729258333,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日21时32分，Inventiva Sa股票出现异动，股价快速上涨5.37%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.16%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410182132139f4d89a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410182132139f4d89a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2476178232","title":"Inventiva Sa盘中异动 早盘股价大跌5.79%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476178232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476178232?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:49","pubTimestamp":1729172996,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时49分，Inventiva Sa股票出现波动，股价大幅下跌5.79%。截至发稿，该股报2.28美元/股，成交量1.3141万股，换手率0.03%，振幅2.89%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.23%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017214956971a0d84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017214956971a0d84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2475227992","title":"Inventiva Sa盘中异动 早盘快速跳水10.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475227992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475227992?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:31","pubTimestamp":1729085473,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时31分，Inventiva Sa股票出现波动，股价快速跳水10.38%。机构评级方面，在所有8家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.34%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410162131139f47d18e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410162131139f47d18e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2475685284","title":"Inventiva Sa盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475685284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475685284?lang=zh_cn&edition=full","pubTime":"2024-10-15 21:40","pubTimestamp":1728999624,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日21时40分，Inventiva Sa股票出现波动，股价快速下挫5.24%。截至发稿，该股报2.53美元/股，成交量13.7747万股，换手率0.26%，振幅2.62%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.09%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101521402498e3c89a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101521402498e3c89a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2475362200","title":"Inventiva Sa盘中异动 早盘股价大涨39.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475362200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475362200?lang=zh_cn&edition=full","pubTime":"2024-10-14 21:31","pubTimestamp":1728912680,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日21时31分，Inventiva Sa股票出现波动，股价大幅拉升39.15%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tevogen Bio Holdings Inc.、Longboard Pharmaceuticals, Inc.涨幅较大，Aditxt, Inc.、Virpax Pharmaceuticals, Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为62.68%、40.73%、27.86%，振幅较大的相关个股有Inventiva Sa、Tevogen Bio Holdings Inc.、Mustang Bio, Inc.，振幅分别为11.11%、10.54%、10.45%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101421312195a748a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101421312195a748a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2474977961","title":"Inventiva Sa盘中异动 快速上涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474977961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474977961?lang=zh_cn&edition=full","pubTime":"2024-10-11 03:27","pubTimestamp":1728588466,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日03时27分，Inventiva Sa股票出现异动，股价大幅拉升5.52%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.40%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101103274698e3bc79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101103274698e3bc79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2473710340","title":"Inventiva Sa盘中异动 股价大跌6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473710340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473710340?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:30","pubTimestamp":1728307846,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时30分，Inventiva Sa股票出现波动，股价急速跳水6.49%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.00%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213046ab681a53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213046ab681a53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2472300994","title":"Inventiva Sa盘中异动 下午盘急速下跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472300994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472300994?lang=zh_cn&edition=full","pubTime":"2024-10-02 02:02","pubTimestamp":1727805723,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日02时02分，Inventiva Sa股票出现异动，股价快速下挫5.09%。截至发稿，该股报1.77美元/股，成交量1.178万股，换手率0.02%，振幅5.90%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.04%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100202020398e3a04c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100202020398e3a04c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2470731457","title":"Inventiva Sa盘中异动 早盘急速下挫12.47%报1.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470731457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470731457?lang=zh_cn&edition=full","pubTime":"2024-09-26 21:34","pubTimestamp":1727357650,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日21时34分，Inventiva Sa股票出现波动，股价大幅跳水12.47%。截至发稿，该股报1.90美元/股，成交量1.6424万股，换手率0.03%，振幅9.82%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.31%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926213410957f7a68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926213410957f7a68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","KTTA","BK4139"],"gpt_icon":0},{"id":"2469242891","title":"Inventiva Sa盘中异动 临近收盘股价大涨6.82%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469242891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469242891?lang=zh_cn&edition=full","pubTime":"2024-09-24 03:41","pubTimestamp":1727120479,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日03时41分，Inventiva Sa股票出现异动，股价快速上涨6.82%。截至发稿，该股报2.19美元/股，成交量1017股，换手率0.00%，振幅2.67%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为2.73%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409240341199719c43f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409240341199719c43f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2462937391","title":"Inventiva Sa盘中异动 股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462937391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462937391?lang=zh_cn&edition=full","pubTime":"2024-08-27 21:32","pubTimestamp":1724765560,"startTime":"0","endTime":"0","summary":"北京时间2024年08月27日21时32分，Inventiva Sa股票出现波动，股价快速上涨5.42%。截至发稿，该股报2.53美元/股，成交量80股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.13%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082721324095c95bb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082721324095c95bb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://inventivapharma.com","stockEarnings":[{"period":"1week","weight":-0.022},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0988},{"period":"6month","weight":-0.2705},{"period":"1year","weight":-0.3206},{"period":"ytd","weight":-0.4088}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inventiva S.A.成立于2011年，并于2016年注册成立。该公司是一家临床阶段的生物制药公司，致力于开发口服小分子疗法，以治疗非酒精性脂肪性肝炎或NASH，粘多糖酶或MPS以及其他未满足医疗需求的严重疾病。该公司建立了一个由发现引擎支持的管道，该发现引擎具有广泛的专有分子库，一个全资研发设施以及一个在开发针对核受体，转录因子和表观遗传调控的化合物方面拥有丰富专业知识和经验的团队。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.033773},{"month":2,"riseRate":0.5,"avgChangeRate":-0.02424},{"month":3,"riseRate":0,"avgChangeRate":-0.114231},{"month":4,"riseRate":0,"avgChangeRate":-0.166714},{"month":5,"riseRate":0.75,"avgChangeRate":0.155722},{"month":6,"riseRate":0.25,"avgChangeRate":-0.133608},{"month":7,"riseRate":0.25,"avgChangeRate":-0.09757},{"month":8,"riseRate":0.2,"avgChangeRate":0.009571},{"month":9,"riseRate":0.4,"avgChangeRate":-0.030876},{"month":10,"riseRate":0.8,"avgChangeRate":0.137564},{"month":11,"riseRate":0.4,"avgChangeRate":-0.026412},{"month":12,"riseRate":1,"avgChangeRate":0.075845}],"exchange":"NASDAQ","name":"Inventiva S.A.","nameEN":"Inventiva S.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inventiva S.A.(IVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inventiva S.A.,IVA,Inventiva S.A.股票,Inventiva S.A.股票老虎,Inventiva S.A.股票老虎国际,Inventiva S.A.行情,Inventiva S.A.股票行情,Inventiva S.A.股价,Inventiva S.A.股市,Inventiva S.A.股票价格,Inventiva S.A.股票交易,Inventiva S.A.股票购买,Inventiva S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inventiva S.A.(IVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}